SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Indo US Bio-Tech

BSE: 541304 29 Jul 2025
Fast Moving Consumer Goods
₹ 155.95
Indo US Bio-Tech Limited specializes in Other Agricultural Products within the Fast Moving Consumer Goods sector.

Indo US Bio-Tech - Share Price & Details

Market Cap
₹327.0
High /Low
388.0 / 138.0
Stock P/E
64.7
Book Value
₹21.0
Dividend Yield
0.15
ROCE
15.4
ROE
₹16.9
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹48.8
Debt
12.8
CMP / FCF
-230.0
Debt to equity
₹0.33
NP Ann
5.06
High price all time
388.0
Piotroski score
₹5.0
Graham Number
36.2
No. Eq. Shares
2.01
Net CF
₹-0.09
Net profit
5.06
Price to book value
7.71
Interest Coverage
₹5.43
Low price all time
0.0
Industry PE
22.9
Reserves
₹29.3
Free Cash Flow
₹-1.27

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Coromandel Agro Products & Oils Ltd619.1717.87618.8522.620.20.05
Abhijit Trading Co. Ltd.2.01-0.570.66-0.020
Indo US Bio-Tech Limited335.0436.85333.851.86327.064.7
Davangere Sugar Company Limite574.7519.43569.070.2231628.9
Aveer Foods Limited269.356.09268.901.5131479.8

Peer Comparison Chart


About Indo US Bio-Tech

Indo US Bio-Tech Limited, with Security Code 541304, is a leading player in the Other Agricultural Products industry, categorized under the Fast Moving Consumer Goods sector, offering Equity instruments.


Latest News

Indo Us Bio-Tech Limited (NSE:INDOUS) Stock Rockets 25% But Many Are Still Ignoring The Company

(22 Jul 2025)
Indo Us Bio-Tech Limited ( NSE:INDOUS ) shareholders would be excited to see that the share price has had a great...
Read more →

These 4 Measures Indicate That Indo Us Bio-Tech (NSE:INDOUS) Is Using Debt Reasonably Well

(19 Jul 2025)
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Read more →

Indo US Bio-Tech Ltd Experiences Notable Turnaround Amid Market Fluctuations

(06 Jun 2025)
Indo US Bio-Tech Ltd experienced notable trading activity today, reaching its upper circuit limit after a four-day decline.
Read more →

Is Weakness In Indo Us Bio-Tech Limited (NSE:INDOUS) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

(29 May 2025)
Indo Us Bio-Tech (NSE:INDOUS) has had a rough three months with its share price down 18%. But if you pay close...
Read more →

Indo US Bio-Tech Reports Strong Profit Growth and Record Net Sales in May 2025

(29 May 2025)
Indo US Bio-Tech has announced its financial results for the quarter ending March 2025, showcasing a significant increase in Profit After...
Read more →

Q4 results: Aurobindo Pharma, Shilpa Medicare, Nazara Technologies to announce March quarter numbers on May 26; check details

(29 May 2025)
Auropbindo Pharma, Shilpa Medicare, Yathath Hospital, Nazara Technologies, Olectra Greentech, Orchid Pharma, RateGain Travel technologies...
Read more →

Company Updates